3
Oct 14 (Reuters) – Parabilis Medicines Inc: * PARABILIS MEDICINES INITIATES DOSE-RANGING CLINICAL STUDY OF ZOLUCATETIDE IN FAMILIAL ADENOMATOUS POLYPOSIS * PARABILIS MEDICINES – TO DISCLOSE ADDITIONAL
(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)
